Alliance to Cure's Summer Research Program

About Alliance to Cure Cavernous Malformation

Alliance to Cure Cavernous Malformation (ACCM) is a non-profit organization with the mission to inform, support, and mobilize those affected by cavernous malformations and drive research for better treatments and a cure. Among other things, we work to expand our patient identification, support, and clinical center program for special populations and their providers, including Black patients. ACCM works closely with academic researchers, treatment developers, government, and medical professionals to change the future. We have hosted the International CCM Scientific Meeting since 2005. We develop and recognize a CCM Centers of Excellence network that provides multi-disciplinary expert care. In one way or another, we are involved in every existing research project and treatment development program. We advocate for legislation to get more grant funding into the hands of researchers. In short, we drive research and we advance better care.

Summer Research Program Description

The Alliance to Cure Cavernous Malformation Summer Research Program is designed for Morehouse School of Medicine students who have completed their first year and have an interest in neurology research. Students may join a research project underway at a CCM Clinical Center, Center of Excellence or a major research lab where research is already supported by ACCM.

Our Goal

The goal of the ACCM Summer Research Program is to expose students to the field of neurological research while experiencing a real time research project. It is expected that students will develop practical research skills while working directly with a neurology researcher in an excellent institution. The research period will last for a period of eight
weeks: June 1—July 31, 2024. Each researcher will receive a one-time grant of $4,000.

Impact

ACCM seeks to increase diversity in the number of practicing neurologists supporting the next generation of neurological researchers from underrepresented communities. Currently, 3% or fewer of neurologists are Black, and this has an impact on the diagnoses and quality of care received by patients with stroke, epilepsy, Parkinson’s disease, dementia, headache, Alzheimer’s, and CCM. At least ¾ of the ACCM Grants will be reserved for students who identify as being from a racial and/or ethnic group that is underrepresented in the scientific workforce as defined by the NSF and NIH. The following groups have been shown nationally to be underrepresented in biomedical research: Blacks or African Americans, Hispanics or Latinos, American Indian or Alaska Native, Native Hawaiians and other Pacific Islanders. Please refer to Section A of the following NIH guideline to confirm eligibility.

Application Timeline & Review

A full application must be submitted by the deadline that meets all guideline criteria as well as all eligibility criteria; otherwise, it will be rejected.
All applications will be processed after the deadline, not on a rolling basis.t